bioAffinity Technologies (BIAF) Debt to Equity (2022 - 2025)
Historic Debt to Equity for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to $0.0.
- bioAffinity Technologies' Debt to Equity fell 2939.68% to $0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.0, marking a year-over-year decrease of 2939.68%. This contributed to the annual value of $0.01 for FY2024, which is N/A changed from last year.
- As of Q3 2025, bioAffinity Technologies' Debt to Equity stood at $0.0, which was down 2939.68% from -$0.02 recorded in Q2 2025.
- bioAffinity Technologies' Debt to Equity's 5-year high stood at $0.04 during Q3 2022, with a 5-year trough of -$0.02 in Q2 2025.
- In the last 4 years, bioAffinity Technologies' Debt to Equity had a median value of $0.01 in 2024 and averaged $0.01.
- The largest annual percentage gain for bioAffinity Technologies' Debt to Equity in the last 5 years was 66345.59% (2025), contrasted with its biggest fall of 42440.14% (2025).
- bioAffinity Technologies' Debt to Equity (Quarter) stood at $0.02 in 2022, then crashed by 77.07% to $0.01 in 2023, then soared by 48.36% to $0.01 in 2024, then plummeted by 36.76% to $0.0 in 2025.
- Its last three reported values are $0.0 in Q3 2025, -$0.02 for Q2 2025, and $0.03 during Q1 2025.